Loading stock data…
Loading stock data…
US$279.14
Get one email when ALNY crosses your level. Checked every 15 minutes during market hours.
▼ -2.12 (-0.75%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
38.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.67
Bearish momentumMACD below its signal line (1.83).
50-day average
295.24
Price belowShort-term trend reference.
200-day average
360.82
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root causes of diseases at the genetic level, offering potential treatments for rare and prevalent conditions across multiple therapeutic areas. The company specializes in creating transformational medicines that address unmet medical needs in sectors such as rare diseases, cardiometabolic disorders, and o…
www.alnylam.com8 strong buy · 21 buy · 9 hold · 0 sell · 0 strong sell (38 analysts, 2026-07-01)
7 strong buy · 21 buy · 9 hold · 0 sell · 0 strong sell (37 analysts, 2026-06-01)
7 strong buy · 20 buy · 9 hold · 0 sell · 0 strong sell (36 analysts, 2026-05-01)
7 strong buy · 20 buy · 9 hold · 0 sell · 0 strong sell (36 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-26 | -0.12 | 0.05 | ✓ Beat |
| 2026-04-30 | 1.47 | 1.99 | ✓ Beat |
| 2026-02-12 | 1.5 | 1.25 | ✗ Miss |
| 2025-10-30 | 1.75 | 2.9 | ✓ Beat |
| 2025-07-31 | 0.15 | 0.32 | ✓ Beat |
| 2025-05-01 | -0.37 | -0.01 | ✓ Beat |
| 2025-02-13 | -0.14 | 0.06 | ✓ Beat |
| 2024-10-31 | -0.39 | -0.5 | ✗ Miss |
Companies in the same industry, via Finnhub